` CYTO (Altamira Therapeutics Ltd) vs S&P 500 Comparison - Alpha Spread

CYTO
vs
S&P 500

Over the past 12 months, CYTO has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.

Stocks Performance
CYTO vs S&P 500

Loading
CYTO
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CYTO vs S&P 500

Loading
CYTO
S&P 500
Difference
www.alphaspread.com

Performance By Year
CYTO vs S&P 500

Loading
CYTO
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Altamira Therapeutics Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Altamira Therapeutics Ltd
Glance View

Market Cap
300k USD
Industry
Pharmaceuticals

Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders.

CYTO Intrinsic Value
Not Available
Back to Top